Hurych and colleagues compared TNF inhibitors in CD and juvenile idiopathic arthritis (JIA) and found no changes in the fecal microbiome or metabolome for the JIA population, in contrast to the CD patients. Here, TNF is linked to juvenile idiopathic arthritis.